常染色体显性Alport综合征的囊性表型与慢性肾脏病
BACKGROUND: Autosomal dominant Alport Syndrome (ADAS), also known as thin basement membrane disease (TBMD), is caused by pathogenic variants in the COL4A3 and COL4A4 genes.…
要点
- ADAS患者中多囊肾表型常见,检出率约52%。
- 合并多囊肾者肾功能更差、eGFR下降更快。
- 未发现COL4A3/COL4A4以外的囊性肾病相关致病变异。
核心结论
- 多囊肾在ADAS中常见,并与更差的肾脏结局相关。
- 除COL4A3/COL4A4外未发现其他致病基因变异。
研究设计与样本
- 平均随访9.4±9.6年。
主要发现
- 16例(52%)检出多囊肾,平均每肾囊肿数12.7±5.5个。
- 101个其他家族性血尿、FSGS及囊性肾病相关基因 panel 未发现遗传异常。
临床怎么用
- 对ADAS患者应关注影像学囊性表型,合并多囊肾提示肾功能恶化风险更高。
- 管理上需重视蛋白尿控制,因其与eGFR年下降独立相关。
局限性
- 随访时间有限,平均9.4年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant Alport Syndrome (ADAS), also known as thin basement membrane disease (TBMD), is caused by pathogenic variants in the COL4A3 and COL4A4 genes. A cystic phenotype has been described in some patients with TBMD, but no genetic studies have been performed. We conducted a genetic and radiologic investigation in a cohort of ADAS patients to analyze the prevalence of multicystic kidney disease (MKD) and its association with chronic kidney disease (CKD). METHODS: This was a retrospective single-center cohort study. Thirty-one patients showing pathogenic or likely pathogenic variants in COL4A3 or COL4A4 from a cohort of 79 patients with persistent microscopic hematuria were included. Mean follow-up was 9.4 ± 9.6 years. The primary objective of the study was to determine the prevalence of MKD in the cohort of ADAS patients. Secondary objectives were to determine risk factors associated with an estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m2 at the time of genetic and radiologic evaluation and to investigate the coexistence of other genetic abnormalities associated with familial hematuria and cystic kidney disease. RESULTS: MKD was found in 16 patients (52%). Mean number of cysts per kidney was 12.7 ± 5.5. No genetic abnormalities were found in a panel of 101 other genes related to familial hematuria, focal segmental glomerulosclerosis and cystic kidney disease. A greater number of patients with MKD had an eGFR <45 mL/min/1.73 m2 (63% vs 7%, P = .006) and more advanced CKD than patients without MKD. The annual rate of eGFR decline was greater in patients with MKD: -1.8 vs 0.06 mL/min/1.73 m2/year (P = .009). By multivariable linear regression analysis, the main determinants of eGFR change per year were time-averaged proteinuria (P = .002) and MKD (P = .02). CONCLUSION: MKD is commonly found in ADAS and is associated with a worse kidney outcome. No pathogenic variants were found in genes other than COL4A3/COL4A4.
引用
- Bada-Bosch T, Sevillano AM, Sánchez-Calvin MT, et al. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome. Nephrol Dial Transplant. 2024. PMID: 38178635. doi:10.1093/ndt/gfae002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。